Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[When and how should hyperprolactinemia be treated?].

Anne Bachelot1, Carine Courtillot, Philippe Touraine

  • 1Service d'endocrinologie et médecine de la reproduction, Hôpital Necker, Paris (75).

Presse Medicale (Paris, France : 1983)
|July 20, 2005
PubMed
Summary

Hyperprolactinemia, elevated prolactin levels, disrupts the reproductive axis, causing menstrual issues in women and sexual dysfunction in men. Dopamine agonists are the primary treatment for prolactinomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRAF-MEK inhibition in a giant BRAF-mutant Rathke cleft cyst: Diagnostic challenges and clinical implications for BRAF testing.

Neuro-oncology practice·2026
Same author

Early Metabolic Risk in Childhood Brain Cancer Survivors with Childhood-Onset Growth Hormone Deficiency.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study.

Maturitas·2026
Same author

The polystyrene beads sign: a simple MRI marker for the preoperative diagnosis of papillary hypothalamic craniopharyngiomas.

European journal of endocrinology·2026
Same author

Beyond the conventional risk factors in the management of atherosclerosis in women: a call to action for careful consideration of obesity and inflammation.

European heart journal open·2026
Same author

Is a systematic adrenocorticotropic hormone (ACTH) stimulation test useful in diagnosing nonclassical congenital adrenal hyperplasia (NCAH)?

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026

Area of Science:

  • Endocrinology
  • Reproductive Medicine

Context:

  • Hyperprolactinemia impacts the hypothalamic-pituitary-gonadal axis.
  • Clinical manifestations include amenorrhea, menstrual irregularities, galactorrhea in women, and sexual dysfunction or tumor-related issues in men.

Purpose:

  • To outline the diagnosis and management of hyperprolactinemia.
  • To discuss treatment strategies for prolactinomas and drug-induced hyperprolactinemia.

Summary:

  • Diagnosis is aided by radioimmunoassays, with MRI used to detect pituitary tumors after ruling out secondary causes like drug reactions.
  • Dopaminergic agonists, particularly cabergoline, are the first-line treatment for prolactin adenomas due to high efficacy and lower relapse rates than surgery.
  • Management during pregnancy varies: dopamine agonists are continued for macroadenomas and withdrawn for microadenomas.

Impact:

  • Provides a concise overview of hyperprolactinemia management.
  • Highlights the importance of differentiating causes and tailoring treatment, especially for fertility and during pregnancy.
  • Emphasizes the role of dopaminergic agonists as a cornerstone therapy.

Related Experiment Videos